Taking a GLP-1 drug? Here's what the safety evidence really shows
A review on GLP-1 receptor agonists highlights risks like pancreatitis and thyroid cancer, emphasizing individual patient risk over general safety concerns.
Read original article on The Medical News →Related news
-
Young mothers see rapid increase in substance-related emergency department visits
United Kingdom
-
Remission achievable with usual care for axial spondyloarthritis
United Kingdom
-
Heart drug combo reduces kidney damage in septic shock surgery, major trial finds
United Kingdom
-
Implantable device uses ultrasound to improve drug delivery to the brain
United Kingdom
-
Patient-reported outcomes worse for patients with rheumatoid arthritis discontinuing TNF inhibitor
United Kingdom
-
Next-generation drug reduces endometrial cancer progression and death in trial
United Kingdom
-
Trust and inclusive language key to effective vaccination campaigns, report finds
United Kingdom
-
Understanding the symptoms and treatments of pelvic organ prolapse
United Kingdom